John Bamforth

Bamforth has been a highly successful executive for over 30 years in the pharmaceutical and life sciences industry. He held a number of cross-functional roles and is best known for his successes in an array of commercial roles. These experiences include broad global strategy roles in building blockbuster brands, such as Cialis. He was instrumental to the success of the largest restructure in Lilly’s history in 2013. Bamforth has recently retired as Vice President and Chief Marketing Officer for Lilly’s $6 B Biomedicines business unit. He has been active in business development, most notably the recent $960M acquisition of CoLucid. He is the Lilly chair of a partnership with Pfizer in the development of a chronic pain brand and has lead launches with biotech companies such as ICOS, United Therapeutics, and Acrux. He received his bachelor's degree in Pharmacy from the University of Bath and his Ph.D. in neuropharmacology from Aston University in the United Kingdom. Pharmavoice named John one of Pharma’s top 100 ‘Inspirational Leaders’ in 2007 and Aston University awarded him an Honorary Doctorate for service to the Pharma Industry in 2012.